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Pyoderma gangrenosum, cystic acne, and aseptic arthritis are clinically distinct disorders within the broad class of
inflammatory diseases. Although this triad of symptoms is rarely observed in a single patient, a three-generation
kindred with autosomal-dominant transmission of these three disorders has been reported as “PAPA syndrome”
(MIM 604416). We report mapping of a disease locus for familial pyoderma gangrenosum–acne–arthritis to the
long arm of chromosome 15 (maximum two-point LOD score, 5.83; recombination fraction [v] 0 at locusD15S206).
Under the assumption of complete penetrance, haplotype analysis of recombination events defined a disease interval
of 10 cM, between D15S1023 and D15S979. Successful identification of a single disease locus for this syndrome
suggests that these clinically distinct disorders may share a genetic etiology. These data further indicate the role of
genes outside the major histocompatibility locus in inflammatory disease.
Pyoderma gangrenosum, cystic acne, and aseptic ar-
thritis are clinically distinct members of the large class
of inflammatory diseases. Like other disorders that com-
prise this diverse class, including inflammatory bowel
disease, psoriasis, uveitis, and hidradenitis suppurativa,
these diseases are frequently syndromal; clinical mani-
festations of one condition can signal predisposition to
development of other inflammatory disorders (Holt et
al. 1980; Rosner et al. 1993; Bhalla and Sequeira 1994;
Shenefelt 1996). The coincidence of pyogenic sterile ar-
thritis, pyoderma gangrenosum, and acne (PAPA syn-
drome [MIM 604416]) has been reported as an unusual
triad that segregated as an autosomal-dominant disorder
in one kindred (Lindor et al. 1997).
Pyoderma gangrenosum is a painful, ulcerating skin
disease characterized by erythematous papulopustules
that evolve, within days, to necrotic ulcers with elevated,
overhanging borders; lesions are located most frequently
on the lower limbs or at the sites of minor trauma or
surgery (Callen and Taylor 1978). In the most-compre-
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hensive study to date (encompassing 85 patients with
pyoderma gangrenosum), 78% of patients manifested at
least one additional inflammatory disease, most com-
monly arthritis or inflammatory bowel disease but also
monoclonal gammopathy, hidradenitis suppurativa, and
acne conglobata (Powell et al. 1985), among others. In
a smaller study, the incidence of associated disease in
patients with pyoderma gangrenosumwas closer to 50%
(Prystowsky et al. 1989). Although pyoderma gangren-
osum is not widely considered to be a genetic disorder,
three kindreds with autosomal-dominant transmission
of pyoderma gangrenosum have been reported (Bundino
and Zina 1984; Shands et al. 1987; Girardin et al. 1988).
Cystic acne is a common clinical condition, affecting
10%–20% of adolescents and young adults with varying
severity. The pathognomic lesion of cystic acne, most
often found on the forehead, cheeks, nose, and chin, is
the comedone, a small cyst that forms in a hair follicle
when the follicular orifice is blocked by sebum or ker-
atin. Although acne vulgaris, the most common form of
cystic acne, is rarely accompanied by other inflammatory
disorders, a more-severe form, acne conglobata, char-
acterized by multiple cysts with bridging scars, has been
associated with inflammatory arthritis, polyarthralgia,
and pyoderma gangrenosum (Cros et al. 1981; Knitzer
and Needleman 1991; Piazza and Giunta 1991). Cystic
acne is rarely considered to be an inherited disease.
A panoply of arthropathies have been observed in con-
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junction with inflammatory disorders. Joint involvement
may be polyarticular or pauciarticular, symmetrical or
asymmetrical, and axial or peripheral (Piazza and
Giunta 1991; Rosner et al. 1993; Bhalla and Sequeira
1994). Joint inflammation can also have a variety of
outcomes, ranging from full recovery to substantial loss
of function and destruction of the joint space (Mielants
et al. 1987a; Gladman 1995). Although aseptic arthritis
is rarely associated with acne or pyoderma, it has been
tied to inflammatory bowl disease (Mielants et al. 1987b;
Finch 1989; De Vos et al. 1996), uveitis, hidradenitis
suppurativa (Bhalla and Sequeira 1994), and psoriasis
(De Vos et al. 1996). The etiology of inflammatory ar-
thritis is likely multifactorial, but genetic predisposition,
particularly HLA haplotype (Clemens et al. 1985; Mor-
ling et al. 1985; Mielants et al. 1987b; Mierau et al.
1988; Puttick et al. 1990), may play an important role.
Our aim was to define the genetic etiology for heri-
table pyogenic sterile arthritis, pyoderma gangrenosum,
and acne. We therefore reviewed the clinical status of
family 1R members before we initiated genetic linkage
analyses. Twenty-three (56%) surviving members of
family 1R (fig. 1A) exhibited the pleiotropic features of
this syndrome: early childhood onset of intermittent ster-
ile pauciarticular, peripheral erosive arthritis; severe cys-
tic acne beginning in adolescence and persisting into
adulthood; and pyoderma gangrenosum. PAPA syn-
drome was recognized in two children who were initially
considered to be unaffected in the clinical report of Lin-
dor et al. (1997). Individual III-5 had arthritis develop
at age 8 years, and individual III-9 had pyoderma gan-
grenosum and acne develop at age 12 years. Some af-
fected individuals had additional findings: six (46%) re-
ported that sterile abscesses formed at the site of parental
injections, three (23%) had normocytic pancytopenia
develop after taking sulfa-containing medications, and
two (15%) experienced sporadic episodes of irritable
bowel syndrome. Laboratory evaluations of affected in-
dividuals were unrevealing: humoral markers of inflam-
matory diseases, including erythrocyte sedimentation
rate, anti-nuclear antibody, rheumatoid factor, and anti-
cardiolipin antibody, were normal or negative. Cultures
of skin and joint fluids were sterile. Joint manifestations
of disease were responsive to treatment with a high-dose
regimen of corticosteroids. In family 1R, there were two
examples of father-to-son transmission and no apparent
correlation between the severity of the phenotype and
the sex of the subject or his or her affected parent.
After informed consent from the study populationwas
obtained in accordance with institutional guidelines, we
performed genetic linkage studies. Polymorphic loci lo-
cated throughout the human genome were amplified
from genomic DNA and were analyzed by use of stan-
dard protocols (Weber and May 1989; Watkins et al.
1993). For linkage studies, adult individuals with two
or more clinical features of PAPA syndrome were clas-
sified as affected. Because medical histories of affected
adults indicated that onset of cystic acne occurred after
puberty, children and young adolescents were classified
as affected if they had pyoderma gangrenosum or ster-
oid-responsive erosive arthritis. LOD scores were cal-
culated by use of the LINKAGE computer program (La-
throp et al. 1984), and we assumed a disease penetrance
of .95.
Since certain HLA haplotypes are associated with py-
oderma and arthritis, polymorphisms within the MHC
class I locus on chromosome 6 were initially analyzed
and linkage was excluded (data not shown). Thereafter,
a systematic genomewide search was conducted by use
of highly polymorphic loci. We analyzed 93 loci, ex-
cluding ∼70% of the genome, before evidence of linkage
was detected with locus D15S652 (LOD score, 2.37;
recombination fraction [v] 0).
To refine the disease locus, analyses of 15 additional
polymorphic loci from this region of chromosome 15q
were performed (fig. 1B; data not shown).Maximal two-
point LOD scores of 5.83 ( ) were obtained withv = 0
three fully informative loci: D15S969, D15S206, and
D15S152, indicating odds of 20,000:1 that the disease-
causing gene is encoded in this region. Maximum two-
point LOD scores of 3.31 ( ) were obtained by usev = 0
of samples from affected individuals only.
A disease haplotype was constructed from genotypes
segregating with disease in family 1R (fig. 1A). Recom-
binant haplotypes in eight individuals were analyzed, to
determine the boundaries of the disease locus (fig. 1B);
crossover events in two unaffected individuals (III-13,
age 10 years; and III-7, age 9 years) defined a 10-cM
disease locus bounded by lociD15S1023 andD15S979.
A larger 36-cM interval bounded by D15S125 and
D15S966 is defined by crossover events in affected in-
dividuals III-2 (age 19 years), III-6 (age 11 years), III-
11 (age 17 years), and III-12 (age 16 years).
Our results demonstrate that a pleiotropic inflam-
matory syndrome characterized by pyoderma gangren-
osum, cystic acne, and erosive arthritis maps to chro-
mosome 15q between loci D15S1023 and D15S979.
Although identification of a single disease locus provides
indirect evidence that these clinically distinct entities
share a common genetic component, proof of this hy-
pothesis awaits studies that use cloning and the func-
tional characterization of the causal gene or genes within
the identified disease locus.
These data contribute to the growing body of litera-
ture that show that mutated genes outside the MHC
locus can cause inflammatory disease. Genetic studies of
inflammatory disorders once focused on the identifica-
tion of predisposing HLA haplotypes, most significantly
HLA-B27, in populations of patients with ankylosing
spondylitis, sacroiliitis, psoriasis, and pyoderma (Wood-
Figure 1 A, Pedigree of family 1R and PAPA-syndrome disease haplotypes. The clinical status (blackened symbols, affected; unblackened
symbols, unaffected; gray-shaded symbols, unknown status) and age (italicized in parentheses) of individuals are indicated. Alleles of loci on
chromosome 15 (centromere to telomere) are provided, and the disease haplotype is boxed. Alleles that are discordant with clinical status are
shaded. B, Schematic map of chromosome 15q loci studied in family 1R, based on sex-averaged genetic distances from the Genetics Location
Database. Discordant haplotypes (indicated by “X” on the pedigree) in unaffected individuals defined a 10-cM disease locus bounded by loci
D15S1023 and D15S979 (unblackened bar). Discordant haplotypes in affected individuals define a 36-cM interval (gray-shaded bar) bounded
by D15S125 and D15S966.
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row 1985; Archer et al. 1988; Mierau et al. 1988). Al-
though these studies were successful in cataloging caus-
ative MHC allotypes, how these alleles predispose their
carriers to inflammatory disease remains a thorny, yet
fundamental, question.
Recently, several groups have used linkage analysis to
identify inflammatory-bowel-disease loci outside the
MHC gene cluster. In addition to the locus for PAPA
syndrome reported here, loci for inflammatory bowel
disease have been mapped on chromosomes 3, 7, 12,
and 16 (Naom et al. 1997; Binder and Orholm 1996;
Ohmen et al. 1996; Parkes et al. 1996; Satsangi et al.
1996). A systemic granulomatous syndrome character-
ized by inflammatory arthritis, skin rash, and uveitis has
been mapped to chromosome 16 (Tromp et al. 1996).
Elucidation of the causative genes at these loci has lagged
behind the identification of disease intervals, and, to
date, non-MHC inflammatory disease genes remain
unknown.
Several intriguing candidate genes have been mapped
to the disease locus identified by these linkage studies.
The leukocyte chemoattractant factor gene (IL-16) lo-
cated on chromosome 15q25 (Cruikshank et al. 1991)
encodes a 56-kD tetrameric glycoprotein produced by
activated T cells that stimulates migration of CD4 lym-
phocytes and monocytes to areas of inflammation
(Cruikshank et al. 1994). It is postulated that IL-16 is
an important mediator of T cell and monocyte recruit-
ment by virtue of its action as a soluble ligand for the
CD4 receptor (Center et al. 1995). IL-16A protein is a
particularly compelling candidate, because of its pivotal
role in inflammatory responses and because a unique
serum factor that enhances the migration of neutrophils
and monocytes has been isolated from a young patient
with pyarthrosis and pyoderma gangrenosum (Jacobs
and Goetzl 1975).
The gene encoding cellular retinoic acid–binding pro-
tein II (CRABP-2) also maps to chromosome 15q25
(Eller et al. 1992). CRABP-2, the predominant form of
retinoic acid–binding protein found in the cytoplasm of
human skin keratinocytes, may participate in shuttling
retinoic acid from the cytoplasm to nuclear receptors or
in titrating intracellular concentrations (Astrom et al.
1991; Elder et al. 1992; Eller et al. 1992; Sanquer et al.
1993). Retinoic acid participates in limb morphogenesis
and induction of differentiation in skin cells and lym-
phocytes. Topical administration provides therapeutic
benefit in dermatologic conditions (Gilchrest 1996);
toxic reactions to retinoic acid include arthralgia, ar-
thritis, leukocytoclastic vasculitis, and erythema no-
dosum (Dubourg et al. 1996; Pfahl and Chytil 1996; De
Francesco et al. 1997). A protein involved in retinoic
acid signaling or homeostasis is therefore an appealing
candidate for the inflammatory processes of PAPA
syndrome.
Whether or not these or other candidate genes are
responsible for the heritable disorder in family 1R, the
linkage results reported here should foster identification
of a gene that, when mutated, causes immune dysre-
gulation and destructive inflammation. We hope that the
identification of additional affected families, refined
mapping of the disease locus, and ultimately definition
of the disease gene will not only improve our under-
standing of the rare syndrome in this kindred but also
contribute to recognition of the full spectrum of inflam-
matory disorders and etiologies. Ultimately, the eluci-
dation of a shared pathogenesis among this group of
diseases may provide insights into the mechanisms by
which normally quiescent tissues become erroneously
inflamed.
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